Gohlke H
Rehabilitationszentrum Bad Krozingen, Bundesrepublik Deutschland.
Wien Klin Wochenschr. 1992;104(11):309-13.
The importance of hypercholesterolemia for the development of atherosclerotic lesions is undebatable. It is less evident, however, whether the progression of established lesions can be influenced by modifying lipid levels. The review of seven controlled angiographic intervention trials shows that different criteria are used to define progression of lesions. The relation of progression to regression (progression/regression ratio), however, is a useful marker for the activity of coronary artery disease. Patients with familial hypercholesterolemia have a progression/regression ratio of between 3 and 7. There is a consistent relationship between the progression/regression ratio and the LDL-/HDL-cholesterol ratio in both control and intervention groups in these trials. Groups with a LDL-/HDL-cholesterol ratio of 5 have six times more progression than regression. If the LDL-/HDL-cholesterol ratio is less than 2.5 regression occurs more often than progression (i.e. progression/regression ratio less than 1). Thus, in the management of hyperlipidemic patients a LDL-/HDL-cholesterol ratio of less than 2.5 should be achieved if regression of atherosclerotic lesions is desired.
高胆固醇血症对动脉粥样硬化病变发展的重要性是无可争议的。然而,已形成的病变进展是否能通过改变血脂水平来影响则不太明确。对七项对照血管造影干预试验的综述表明,用于定义病变进展的标准各不相同。然而,进展与消退的关系(进展/消退比)是冠状动脉疾病活动的一个有用指标。家族性高胆固醇血症患者的进展/消退比在3至7之间。在这些试验的对照组和干预组中,进展/消退比与低密度脂蛋白/高密度脂蛋白胆固醇比之间存在一致的关系。低密度脂蛋白/高密度脂蛋白胆固醇比为5的组,进展比消退多六倍。如果低密度脂蛋白/高密度脂蛋白胆固醇比小于2.5,消退比进展更常发生(即进展/消退比小于1)。因此,在高脂血症患者的管理中,如果希望动脉粥样硬化病变消退,应使低密度脂蛋白/高密度脂蛋白胆固醇比小于2.5。